ParaPharma Boldo 300 is presented in a 10-milliliter multidose vial and reportedly contains 300 milligrams of boldenone undecylenate per milliliter according to label and/or packaging. Samples of this product were purchased from a European-based internet source between the dates of July 15, 2019 and August 29, 2019.The samples were forwarded and received by the analytical laboratory SIMEC AG on August 29, 2019. SIMEC performed HPLC-UV quantitative dosage testing, qualitative ‘total aerobial microbiological count’ (TAMC) testing and qualitative ‘total yeast and mold count’ (TYMC) testing on September 24, 2019. The report was completed on October 15, 2019.
The product was identified with batch number of PARA002 and an expiration date of August 2022.
Label claim: ParaPharma Boldo 300 has a label claim of 300 mg/ml boldenone undecylenate.
Actual content: ParaPharma Boldo 300 was determined to have an actual content of 270 mg/ml boldenone undecylenate.
No microbiological contamination was detected.
The product was identified with batch number of PARA002 and an expiration date of August 2022.
Label claim: ParaPharma Boldo 300 has a label claim of 300 mg/ml boldenone undecylenate.
Actual content: ParaPharma Boldo 300 was determined to have an actual content of 270 mg/ml boldenone undecylenate.
No microbiological contamination was detected.